SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905729-04-000349
Filing Date
2004-09-24
Accepted
2004-09-24 11:53:08
Documents
1
Period of Report
2004-09-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1440
  Complete submission text file 0000905729-04-000349.txt   3313
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Issuer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 7575 FULTON STREET EAST ADA MI 49355-0001
Business Address (616) 787-6642
Viveen William J JR (Reporting) CIK: 0001304185 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23413 | Film No.: 041044208